Zealand Pharma A/S

BiotechnologySeries CDenmarkzealandpharma.com

Latest round

Series C

Last raised

Feb 2005

Total raised

$35M

Investors

6

About Zealand Pharma A/S

Based in Soborg, Denmark, and founded in 1998, Zealand Pharma A/S operates as a biotechnology company that develops peptide-based therapeutics and specialty medicines to treat patients with metabolic, gastrointestinal, and other rare diseases.

Who invested in Zealand Pharma A/S

6 investors across 2 rounds

See all investors in Zealand Pharma A/S

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Feb 21, 2005

    Amount

    $17M

    Investors

    Locked

  2. Series C

    Jan 7, 2005

    Amount

    $18M

    Investors

    Locked

Questions about Zealand Pharma A/S

Who invested in Zealand Pharma A/S?

Zealand Pharma A/S has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Zealand Pharma A/S raised?

Zealand Pharma A/S has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Zealand Pharma A/S last raise money?

Zealand Pharma A/S's most recent round on record is a Series C, in Feb 2005.

What does Zealand Pharma A/S do?

Based in Soborg, Denmark, and founded in 1998, Zealand Pharma A/S operates as a biotechnology company that develops peptide-based therapeutics and specialty medicines to treat patients with metabolic, gastrointestinal, and other rare diseases.

Where is Zealand Pharma A/S headquartered?

Zealand Pharma A/S is headquartered in Denmark.

Which VCs invest in companies like Zealand Pharma A/S?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Zealand Pharma A/S's stage. Their profiles are linked below.

Raising like Zealand Pharma A/S? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.